Target intelligence / Profile preview

TOMM20 pseudogene 1 (TOMM20P1)

Target
TOMM20P1
Molecular classification
Other (Pseudogene)
01

Overview

TOMM20 pseudogene 1 (TOMM20P1) is classified as a pseudogene. It is not known to encode a functional protein, is not associated with any known molecular function, biological process, or disease, and is not considered a therapeutic target. Pseudogenes are typically non-functional sequences arising from duplication or retrotransposition events, and TOMM20P1 does not participate in the activities attributed to the functional protein-coding gene TOMM20[5]. TOMM20P1 is a pseudogene, not an active gene or functional protein[5]. There is no evidence it produces a protein or plays a role in signaling, transport, metabolism, or disease. It is not a receptor, enzyme, transporter, or transcription factor. It is not a therapeutic target and has no known interacting drugs, mechanisms of action, or biomarker usage. No disease association or safety concerns have been reported[5]. This entry is sometimes incorrectly queried as a target—researchers are usually interested in TOMM20, the functional mitochondrial import receptor, not TOMM20P1. If more information about the actual mitochondrial receptor (TOMM20) is needed, details can be provided, but TOMM20P1 itself lacks functional and therapeutic interest[5].

Other names
TOMM20P1

Beyond the preview

Go deeper on TOMM20 pseudogene 1 (TOMM20P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TOMM20 pseudogene 1 (TOMM20P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call